These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38947333)

  • 1. Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective.
    González-Cueto E; de la Fuente J; López-Camacho C
    Front Immunol; 2024; 15():1384442. PubMed ID: 38947333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick vaccines and the control of tick-borne pathogens.
    Merino O; Alberdi P; Pérez de la Lastra JM; de la Fuente J
    Front Cell Infect Microbiol; 2013; 3():30. PubMed ID: 23847771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tick and pathogen transmission blocking vaccines.
    van Oosterwijk JG
    Parasite Immunol; 2021 May; 43(5):e12831. PubMed ID: 33704804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives of creation of vaccines against tick bite for nonspecific prophylaxis of vector borne diseases].
    Diatlov IA; Biketov SF; Firstova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):101-6. PubMed ID: 21913400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of Acquired Resistance to Ticks.
    Karasuyama H; Miyake K; Yoshikawa S
    Front Immunol; 2020; 11():601504. PubMed ID: 33154758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tick hypersensitivity and human tick-borne diseases.
    Ng YQ; Gupte TP; Krause PJ
    Parasite Immunol; 2021 May; 43(5):e12819. PubMed ID: 33428244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of the tick-host interaction and the control of ticks and tick-borne diseases.
    Willadsen P; Jongejan F
    Parasitol Today; 1999 Jul; 15(7):258-62. PubMed ID: 10377526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for new and improved vaccines against ticks and tick-borne diseases.
    de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
    Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Transient Immune Tolerance in Ticks and Vertebrate Host: A Keystone of Tick-Borne Diseases?
    Boulanger N; Wikel S
    Front Immunol; 2021; 12():625993. PubMed ID: 33643313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and control strategies for ticks and pathogen transmission.
    de La Fuente J; Kocan KM; Contreras M
    Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upcoming and future strategies of tick control: a review.
    Ghosh S; Azhahianambi P; Yadav MP
    J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
    Artigas-Jerónimo S; De La Fuente J; Villar M
    Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.
    Sprong H; Trentelman J; Seemann I; Grubhoffer L; Rego RO; Hajdušek O; Kopáček P; Šíma R; Nijhof AM; Anguita J; Winter P; Rotter B; Havlíková S; Klempa B; Schetters TP; Hovius JW
    Parasit Vectors; 2014 Feb; 7():77. PubMed ID: 24559082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus.
    Odongo D; Kamau L; Skilton R; Mwaura S; Nitsch C; Musoke A; Taracha E; Daubenberger C; Bishop R
    Vaccine; 2007 Jan; 25(7):1287-96. PubMed ID: 17070625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.